Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Tobacco-related disease is a leading cause of premature mortality for people experiencing mental illness. Tobacco treatment is not routinely provided in psychiatry with systemic barriers preventing access to treatment. This study examines a system change approach, with an incentive payment, to implement tobacco treatment at scale in community psychiatry settings.

Methods: Secondary analysis of statewide health administrative data was conducted. Changes in documentation of smoking status and delivery of a tobacco treatment brief intervention (the Pathway) were evaluated using interrupted time series analysis between July 2017 and June 2023. An implementation period (4 years), divided into incentive payment phases for achievement of pre-defined targets, and a post-incentive payment maintenance period (2 years) were defined.

Results: Documented average smoking rate for community psychiatry during maintenance remained high (52.5%; 95% confidence interval = [52.5, 52.6]). Statewide documentation of smoking status significantly exceeded targets during implementation, reaching 93.9% (95% confidence interval = [93.3%, 94.4%]). Despite a 2.1% decrease (95% confidence interval = [-3.4, -0.8]) after removal of incentive payments, reporting remained high 91.9% (95% confidence interval = [91.5%, 92.3%]). Documentation of the Pathway was significantly higher than targets and showed no change by implementation end (87.0%; 95% confidence interval = [85.9%, 88.1%]) to maintenance where no incentive payments were available (85.7%; 95% confidence interval = [84.9%, 86.5%]).

Conclusions: Delivery of tobacco treatment in psychiatry is an important step to addressing inequity in smoking prevalence, but achieving this has been challenging. Our study demonstrates the potential of a system change intervention to improve care and sustainably deliver tobacco cessation treatment, at scale, in psychiatry settings.

Download full-text PDF

Source
http://dx.doi.org/10.1177/00048674251340214DOI Listing

Publication Analysis

Top Keywords

95% confidence
24
confidence interval
24
tobacco treatment
16
system change
12
community psychiatry
12
change intervention
8
psychiatry settings
8
incentive payment
8
treatment scale
8
documentation smoking
8

Similar Publications

Objective: The cachexia index (CXI) demonstrates potential as both a diagnostic tool for cachexia and a prognostic tool for survival in cancer. However, CXI's predictive value has not been verified in cervical cancer. The purpose of this study is to investigate the prognostic value of the CXI in patients with cervical cancer treated with radiotherapy.

View Article and Find Full Text PDF

Introduction: The high mortality of Coronavirus Disease 2019 (COVID-19) highlights the need for safe and effective antiviral treatment. Small molecular antivirals (remdesivir, molnupiravir, nirmatrelvir/ritonavir) and immunomodulators (baricitinib, tocilizumab) have been developed or repurposed to suppress viral replication and ameliorate cytokine storms, respectively. Despite U.

View Article and Find Full Text PDF

Purpose: Patients diagnosed with high-grade gliomas (HGG) often experience substantial psychosocial dis-tress. However, due to neurological and neurocognitive deficits its assessment remains challenging, and needs remain unmet. We compared a novel face-to-face assessment during doctor-patient conversations with questionnaire-based screening.

View Article and Find Full Text PDF

Patients with acquired and congenital heart disease (CHD) are at higher risk of hospitalization. Despite quality improvement (QI) initiatives, many patients experience readmission soon after discharge. We aimed to identify risk factors for 30-day readmission and hypothesized that direct discharge from the cardiac intensive care unit (CICU) is associated with an increased readmission rate.

View Article and Find Full Text PDF

This study examined trends in the proportion of adults with self-reported hypertension and in antihypertensive medication use among community-dwelling Australian adults. We analysed data from a longitudinal panel study, covering four waves: 2009 (n = 8023), 2013 (n = 11,475), 2017 (n = 12,843), and 2021 (n = 14,571) for adults aged 18-74 years. Hypertension and antihypertensive medication use were self-reported.

View Article and Find Full Text PDF